Dapagliflozin (Farxiga) appears to be no more effective than the "thiazide-like" diuretic metolazone at improving pulmonary congestion and fluid status in patients with acute heart failure (AHF), ...

PRAGUE, Czechia—The number of people taking loop diuretics without a diagnosis of heart failure (HF) may be many times higher than the number of HF patients on these meds, according to an analysis of ...

Starting dapagliflozin (Farxiga) early during acute heart failure hospitalization didn't boost decongestion, although it appeared to spare loop diuretic doses and increase diuresis compared with usual ...

prescription-medications-0416 SHPT risk was 4 times higher among patients taking furosemide vs hydrochlorothiazide. Non-dialysis chronic kidney disease (CKD) patients receiving loop diuretics may have ...

Please provide your email address to receive an email when new articles are posted on . In a cross-sectional analysis, researchers examined 176,448 adults receiving center-based maintenance ...

Early initiation of the sodium glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin did not result in a statistically significant improvement in diuretic efficiency relative to structured usual ...

Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, Wegovy improved HF symptoms and physical limitations in patients with obesity-related ...

Diuretic use following kidney transplant significantly increases the risk of patients developing diabetes, potentially leading to serious complications including graft loss, one of the first studies ...